Racial Differences in Epinephrine and β2-Adrenergic Receptors

Abstract This study examined the effects of ethnicity and hypertension on β 2 -adrenergic receptors and on plasma catecholamines in a group of 77 unmedicated mildly hypertensive and normotensive men. Black hypertensive subjects had the most sensitive and white hypertensive subjects the least sensitive β-receptors (as assessed by isoproterenol-stimulated cyclic AMP in lymphocytes [ P =.02]). In contrast, postreceptor adenylate cyclase activation (as assessed by forskolin stimulation) was similar among groups. As with β-receptor sensitivity, black hypertensive subjects had the highest β-receptor density and white hypertensive subjects the lowest ( P =.03). Blacks demonstrated lower plasma epinephrine values compared with whites ( P =.03). Across all subjects, plasma epinephrine was negatively correlated with β-receptor density ( r =−.26, P r =−.25, P

[1]  J. Dimsdale,et al.  Lymphocyte Subset Redistribution in Response to Acute Experimental Stress: Effects of Gender, Ethnicity, Hypertension, and the Sympathetic Nervous System , 1995, Brain, Behavior, and Immunity.

[2]  J. Johnson,et al.  Racial differences in lymphocyte beta-receptor sensitivity to propranolol. , 1993, Life sciences.

[3]  R. Hauger,et al.  Sympathetic alterations after sodium restriction and short-term captopril administration. , 1993, Journal of the American College of Cardiology.

[4]  D. Rutledge.  Are There Beta-Adrenergic Receptor Response Differences between Racial Groups? , 1991, DICP : the annals of pharmacotherapy.

[5]  S. Kilfeather,et al.  Ethnic differences in cyclic AMP accumulation: Effect on α2, β2, and prostanoid receptor responses , 1990 .

[6]  B. Kennedy,et al.  A more sensitive and specific radioenzymatic assay for catecholamines. , 1990, Life sciences.

[7]  H. Motulsky,et al.  A new method for isolation of human lymphocyte subsets reveals differential regulation of β‐adrenergic receptors by terbutaline treatment , 1989, Clinical pharmacology and therapeutics.

[8]  L. Cardozo,et al.  Racial differences in drug response: Isoproterenol effects on heart rate following intravenous metoprolol , 1989, Clinical pharmacology and therapeutics.

[9]  G R Wilkinson,et al.  Racial differences in drug response. Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites. , 1989, The New England journal of medicine.

[10]  J. Bilezikian,et al.  Reduced lymphocyte stimulatory guanine nucleotide regulatory protein and beta-adrenergic receptors in congestive heart failure and reversal with angiotensin converting enzyme inhibitor therapy. , 1988, Circulation.

[11]  L. Lesko,et al.  Steady state relative bioavailability and pharmacokinetics of oral propranolol in black and white North Americans , 1988, Biopharmaceutics & drug disposition.

[12]  J. Dimsdale,et al.  The effect of hypertension, sodium, and race on isoproterenol sensitivity. , 1988, Clinical and experimental hypertension. Part A, Theory and practice.

[13]  J. Dimsdale,et al.  Age, race, diagnosis, and sodium effects on the pressor response to infused norepinephrine. , 1987, Hypertension.

[14]  R. Feldman,et al.  Low sodium diet corrects the defect in lymphocyte beta-adrenergic responsiveness in hypertensive subjects. , 1987, The Journal of clinical investigation.

[15]  O. Brodde,et al.  Human beta-adrenoceptors: relation of myocardial and lymphocyte beta-adrenoceptor density. , 1986, Science.

[16]  A. Daul,et al.  Effect of propranolol, alprenolol, pindolol, and bopindolol on beta 2-adrenoceptor density in human lymphocytes. , 1986, Journal of cardiovascular pharmacology.

[17]  P. Joubert,et al.  Ethnic differences in human lymphocytic cyclic AMP production after isoprenaline stimulation and propranolol blockade. , 1985, British journal of clinical pharmacology.

[18]  R. Landmann,et al.  Beta-adrenergic receptors are different in subpopulations of human circulating lymphocytes. , 1984, Journal of receptor research.

[19]  P. Molinoff,et al.  Decreased beta adrenergic receptor density on human lymphocytes after chronic treatment with agonists. , 1983, The Journal of pharmacology and experimental therapeutics.

[20]  D. Goldstein,et al.  Plasma catecholamines and essential hypertension. An analytical review. , 1983, Hypertension.

[21]  D. Robertson,et al.  Regulation of human leukocyte beta receptors by endogenous catecholamines: relationship of leukocyte beta receptor density to the cardiac sensitivity to isoproterenol. , 1981, The Journal of clinical investigation.

[22]  J. Daly,et al.  Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.